Off-Label Prescribing With Limited Evidence: What We Have To Lose

Randomized clinical trials are the core of how government regulators prevent dangerous drugs from reaching patients. That’s for good reason. Though some prescriptions can be made ethically without the backing of a placebo-controlled, double-blind randomized control trial, these situations are and should remain the exception, not the rule.

READ MORE

Things Fall Apart

Stay-at-Home orders are now expiring in many US states. In some places where orders remain in force, compliance is weakening. The US has not used

READ MORE

COVID-19 and health care fraud

Colleagues Melissa Garrido and Michael Adelberg have published a piece on the Health Affairs blog about health care fraud pertaining to COVID-19. The COVID-19 epidemic

READ MORE
Subscribe

Email Address*